DK2293810T3 - Muteret tat-oyi-protein til forebyggelse eller behandling af aids - Google Patents
Muteret tat-oyi-protein til forebyggelse eller behandling af aidsInfo
- Publication number
- DK2293810T3 DK2293810T3 DK09733706.7T DK09733706T DK2293810T3 DK 2293810 T3 DK2293810 T3 DK 2293810T3 DK 09733706 T DK09733706 T DK 09733706T DK 2293810 T3 DK2293810 T3 DK 2293810T3
- Authority
- DK
- Denmark
- Prior art keywords
- muterated
- oyi
- tat
- aids
- protein
- Prior art date
Links
- 208000030507 AIDS Diseases 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/21—Retroviridae, e.g. equine infectious anemia virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
- C12N2740/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
- C12N2740/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4685608P | 2008-04-22 | 2008-04-22 | |
| US5379008P | 2008-05-16 | 2008-05-16 | |
| PCT/EP2009/054846 WO2009130256A2 (en) | 2008-04-22 | 2009-04-22 | Compositions and methods for preventing or treating aids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2293810T3 true DK2293810T3 (da) | 2014-09-22 |
Family
ID=41119538
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK09733706.7T DK2293810T3 (da) | 2008-04-22 | 2009-04-22 | Muteret tat-oyi-protein til forebyggelse eller behandling af aids |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US8999350B2 (da) |
| EP (1) | EP2293810B1 (da) |
| JP (1) | JP5616327B2 (da) |
| CN (1) | CN102056618B (da) |
| AU (1) | AU2009240006B2 (da) |
| CA (1) | CA2722240C (da) |
| CY (1) | CY1115541T1 (da) |
| DK (1) | DK2293810T3 (da) |
| ES (1) | ES2500265T3 (da) |
| HK (1) | HK1152861A1 (da) |
| HR (1) | HRP20140819T1 (da) |
| IL (1) | IL208862A (da) |
| NZ (1) | NZ588864A (da) |
| PL (1) | PL2293810T3 (da) |
| PT (1) | PT2293810E (da) |
| SI (1) | SI2293810T1 (da) |
| WO (1) | WO2009130256A2 (da) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011078426A1 (ko) * | 2009-12-24 | 2011-06-30 | 연세대학교 산학협력단 | 비만 억제 및 치료용 펩타이드 |
| WO2011128720A1 (en) * | 2010-04-14 | 2011-10-20 | Mymetics Corporation | Trans-activator of transcription protein |
| CN104001155B (zh) * | 2014-06-12 | 2016-04-13 | 中山大学 | 一种Tat蛋白及其制备方法和应用 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2792206B1 (fr) * | 1999-04-13 | 2006-08-04 | Centre Nat Rech Scient | Vaccin anti-vih-1 comprenant tout ou partie de la proteine tat de vih-1 |
| WO2004084805A2 (en) | 2003-03-19 | 2004-10-07 | The J. David Gladstone Institutes | Acetylated tat polypeptides and methods of use thereof |
-
2009
- 2009-04-22 WO PCT/EP2009/054846 patent/WO2009130256A2/en active Application Filing
- 2009-04-22 PL PL09733706T patent/PL2293810T3/pl unknown
- 2009-04-22 CA CA2722240A patent/CA2722240C/en active Active
- 2009-04-22 ES ES09733706.7T patent/ES2500265T3/es active Active
- 2009-04-22 EP EP09733706.7A patent/EP2293810B1/en active Active
- 2009-04-22 US US12/989,165 patent/US8999350B2/en active Active
- 2009-04-22 PT PT97337067T patent/PT2293810E/pt unknown
- 2009-04-22 JP JP2011505502A patent/JP5616327B2/ja active Active
- 2009-04-22 AU AU2009240006A patent/AU2009240006B2/en active Active
- 2009-04-22 NZ NZ588864A patent/NZ588864A/en unknown
- 2009-04-22 CN CN200980121522.4A patent/CN102056618B/zh active Active
- 2009-04-22 SI SI200931007T patent/SI2293810T1/sl unknown
- 2009-04-22 DK DK09733706.7T patent/DK2293810T3/da active
-
2010
- 2010-10-21 IL IL208862A patent/IL208862A/en active IP Right Grant
-
2011
- 2011-05-09 HK HK11104545.9A patent/HK1152861A1/xx unknown
-
2014
- 2014-09-01 HR HRP20140819AT patent/HRP20140819T1/hr unknown
- 2014-09-10 CY CY20141100727T patent/CY1115541T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY1115541T1 (el) | 2017-01-04 |
| IL208862A (en) | 2016-11-30 |
| CN102056618A (zh) | 2011-05-11 |
| JP5616327B2 (ja) | 2014-10-29 |
| CA2722240A1 (en) | 2009-10-29 |
| US8999350B2 (en) | 2015-04-07 |
| JP2011518211A (ja) | 2011-06-23 |
| ES2500265T3 (es) | 2014-09-30 |
| CA2722240C (en) | 2016-09-20 |
| HK1152861A1 (en) | 2012-03-16 |
| EP2293810A2 (en) | 2011-03-16 |
| NZ588864A (en) | 2012-07-27 |
| US20110212118A1 (en) | 2011-09-01 |
| AU2009240006B2 (en) | 2014-11-20 |
| CN102056618B (zh) | 2018-05-01 |
| IL208862A0 (en) | 2011-01-31 |
| AU2009240006A1 (en) | 2009-10-29 |
| PL2293810T3 (pl) | 2014-11-28 |
| EP2293810B1 (en) | 2014-06-11 |
| WO2009130256A2 (en) | 2009-10-29 |
| US20120121632A9 (en) | 2012-05-17 |
| PT2293810E (pt) | 2014-09-16 |
| SI2293810T1 (sl) | 2014-11-28 |
| HRP20140819T1 (hr) | 2014-10-24 |
| WO2009130256A3 (en) | 2009-12-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2448637T3 (da) | Anvendelse af ét fytocannabinoid eller en kombination af fytocannabinoider til behandling af epilepsi | |
| DK2504005T3 (da) | Anvendelse af 1,3-diphenylprop-2-en-1-on-derivater til behandling af lever-sygdomme | |
| DK2498771T3 (da) | Anvendelse af bethanechol til behandling af xerostomi | |
| DK2470191T3 (da) | Fremgangsmåder og præparater til forebyggelse eller behandling af oftalmiske tilstande | |
| DK2086944T3 (da) | Fremgangsmåde til fremstilling af difluormethylpyrazolylcarboxylater | |
| DK2146732T3 (da) | Fremgangsmåder til behandling eller forebyggelse af emese ved hjælp af væksthormonsekretagoger | |
| SMAP200900085A (it) | 3-imidazolil-indoli per il trattamento di malattieproliferative | |
| DK2240130T3 (da) | Indretning til behandling af fedme | |
| DK3289876T3 (da) | Forbindelser til behandling af cancer | |
| DK2114886T3 (da) | Fremgangsmåde til fremstilling af visse substituerede sulfiliminer | |
| DK2349310T3 (da) | Polypeptid til behandling eller forebyggelse af adhæsioner | |
| DK2451796T3 (da) | Tofaanaloger til behandling af dermatologiske lidelser eller tilstande | |
| DK3251678T3 (da) | Benzoxaborolderivater til behandling af bakterieinfektioner | |
| DK2309916T3 (da) | System og fremgangsmåde til ordination af synshjælpemidler | |
| DK2451482T3 (da) | Kombinationsterapi til behandlingen af diabetes | |
| DK2459553T3 (da) | Furazanobenzimidazoler som prodrug til behandling af neoplastiske eller autoimmune sygdomme | |
| DK2209784T3 (da) | Forbindelser til behandling af hepatitis C | |
| DK2382232T3 (da) | Fremgangsmåde til fremstilling af bivalirudin | |
| DK2117565T3 (da) | Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme | |
| DK2164572T3 (da) | Carbamoyl-cyclohexaner til behandling af akut mani | |
| ATE533774T1 (de) | Neuartige nukleosidanaloge zur behandlung von virusinfektionen | |
| DK2249866T3 (da) | Anvendelse af et acetylsalicylsyresalt til behandlingen af virusinfektioner | |
| DK2307445T3 (da) | Fremgangsmåde til fremstilling af caspofungin og mellemforbindelser heraf | |
| DK3216457T3 (da) | Forbindelser og fremgangsmåder til forebyggelsen eller behandlingen af restenose | |
| DK2321359T3 (da) | Fremgangsmåde til behandling af naturlige gummiprodukter |